about
A Review of Sleep and Its Disorders in Patients with Parkinson's Disease in Relation to Various Brain Structures'The clocks that time us'--circadian rhythms in neurodegenerative disordersNeuroanatomical changes in Parkinson's disease in relation to cognition: An updateA clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodiesLevodopa withdrawal syndrome identical to neuroleptic malignant syndromeThe relationship between thermoregulation and REM sleep behaviour disorder in Parkinson's diseaseAutonomic nervous system dysfunction in Parkinson's disease: relationships with age, medication, duration, and severity.Clinical Implications of Cardiac-MIBG SPECT in the Differentiation of Parkinsonian Syndromes.Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research.Sleep and circadian rhythm regulation in early Parkinson diseaseSleep alterations in an environmental neurotoxin-induced model of parkinsonism.The dopamine transporter is decreased in the striatum of subjects with restless legs syndromeWeight changes in subthalamic nucleus vs globus pallidus internus deep brain stimulation: results from the COMPARE Parkinson disease deep brain stimulation cohort.Bladder, bowel, and sexual dysfunction in Parkinson's diseaseNondipping in Parkinson's diseaseAmine accumulation: a possible precursor of Lewy body formation in Parkinson's disease.Hereditary Lewy-body parkinsonism and evidence for a genetic etiology of Parkinson's disease.(123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.Pharmacotherapy of dementia with Lewy bodies.Paraphilias and paraphilic disorders in Parkinson's disease: A systematic review of the literature.Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression.Comparison of the structure, function and autophagic maintenance of mitochondria in nigrostriatal and tuberoinfundibular dopamine neurons.Unique responses to mitochondrial complex I inhibition in tuberoinfundibular dopamine neurons may impart resistance to toxic insult.Consequences of Circadian Disruption on Neurologic Health.Overview of Parkinson's disease.Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease?Obesity, diabetes, and risk of Parkinson's disease.Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's diseaseNeurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a reviewMeta-analysis: overweight, obesity, and Parkinson's disease.Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff.Sustained resistance to acute MPTP toxicity by hypothalamic dopamine neurons following chronic neurotoxicant exposure is associated with sustained up-regulation of parkin protein.Sleep disturbances associated with Parkinson's disease.The Lewy body in Parkinson's disease and related neurodegenerative disorders.Pineal melatonin functions: possible relevance to Parkinson's disease.Mechanisms of action of ECT in Parkinson's disease: possible role of pineal melatonin.Hypothalamic compensatory mechanisms in Parkinson's disease.The neurotoxicity of MPTP and its relationship to the pathophysiology of Parkinson's disease.The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease.Pro-opiomelanocortin (POMC) processing in Parkinson's disease.
P2860
Q26744733-E797D0AF-5AD2-4D81-8C97-17A9959823D7Q26824646-22D8E617-AF03-49DA-8BA9-4CD1C3113431Q28067803-866AA068-CC64-4519-A0EE-BBC98F6DA21DQ28362147-4B9D115F-376E-4E30-B16C-85396F27DCD8Q28362151-9927148B-A8F3-4C90-A404-39E6588CCE14Q31133155-C4050F81-3101-40F9-969A-DFDC1A6EDF9DQ33591893-3EE3CB81-9E8B-4CF1-935B-89EA1492EB8CQ33790729-BD63A587-FF78-48F8-9436-13828BA4BE26Q33874635-912BF9C5-935E-466D-A61B-0B79F9BE13ABQ33992743-36D0E2DD-2CCE-4C8C-A991-1B6A572E3FFCQ34203614-2C613216-F2C9-422D-A39E-542DA13EF0EBQ34585898-BF735DFB-93A5-4FCA-838B-7044704626A6Q34961019-DD161F51-5AED-4FA0-827A-6DDF45E1FFFEQ35209869-2C3BE129-3517-4987-94BB-F61D1DDC5DC6Q35219310-57D7CE6A-E45C-4EB3-B75A-2C1F957CC8E2Q35222898-F94D38EA-F22F-40AC-8F53-F42C626E9AE3Q35243883-48E0E407-3C3F-467B-B0AD-E46DFCCF6F08Q35452165-363EF6AD-E0E5-4C24-A121-6936216D5B6AQ35574995-E0896ABB-9F5D-4BE0-8D55-A6C0EA429CCCQ35595866-E18BEACA-E6B6-44D4-9E54-105B8FC7FBA5Q35997646-714026DB-33BB-44AE-9CC2-C8D8C9EA7C99Q36037330-91C6045F-DA73-4567-A792-7E18CED34ECEQ36083459-388FC01B-296A-47B3-A2E5-23EE30515E4DQ36289339-F6251BFD-6370-4AFF-A066-E3E769F23001Q36349353-6AA1D0F1-50E6-46DC-84B6-D9253122C642Q36665097-F5B4B3D3-C539-4032-AA7F-0788D16EA60FQ36769272-9AE728A5-DDC8-4BF7-BDD7-CCBDE2E92BB8Q37260721-4CA3599B-9453-45C0-BEE7-9EC810236846Q37418238-0179A6BD-0805-4341-A92E-FCFA6EFAAA96Q37615797-536C1D4E-3C3F-4B44-9A6C-9ADA80A7190EQ37693339-CB528F06-1E37-472B-A280-9DE1D2A16D78Q37695513-B58C3691-7DC8-4BF8-9FEB-AF4BAED5F5A4Q37923780-E67CE4A2-66BB-4E98-A8E4-53975F723195Q38012653-DFD02ECB-3B1E-40BB-83EE-D90B7311431BQ38018546-0E3B4090-7966-4018-817C-78B7D06D0199Q38018551-61EC4856-9A55-426D-A5DC-B5B99A3A431BQ38214420-ECF1D0DE-2DFB-4DEB-8399-B1EC3162D6D0Q38214423-65AD6943-3989-44D2-BC86-0D6145D152B9Q38670012-C9A56E8E-CE75-40FD-A156-8651B905D388Q38689155-620FB3D9-EA1B-46BC-A642-EC782B270DA5
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
The hypothalamus in Parkinson disease.
@en
type
label
The hypothalamus in Parkinson disease.
@en
prefLabel
The hypothalamus in Parkinson disease.
@en
P356
P1433
P1476
The hypothalamus in Parkinson disease.
@en
P2093
P304
P356
10.1002/ANA.410030207
P577
1978-02-01T00:00:00Z